November 20, 2008
ST. LOUIS, Nov. 20 -- Sigma-Aldrich (Nasdaq: SIAL) announced today the global release of MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA. MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA are expected to allow researchers to successfully take the next step in their RNAi research with the highest purity and quality siRNA required for RNAi [...]
November 20, 2008
Angstrom Scientific, Inc., a representative for nanoscale level measurement and control manufacturers, announces an agreement with Kleindiek Nanotechnik GmbH to become the sales and service representative for Kleindiek's micro- and nano-manipulation systems for electron microscopy and focused ion beam (FIB) applications in the USA. "The Kleindiek tools for nano-manipulation and characterization are an excellent addition [...]
Dr. Elaine Mardis Joins Pacific Biosciences Scientific Advisory Board
November 20, 2008
Pacific Biosciences, a private company developing third-generation DNA sequencing technology, announced today that Elaine Mardis, Ph.D., co-director of The Genome Center at Washington University School of Medicine, has joined its Scientific Advisory Board. The company also announced that it recently received $20 million in funding from a new investor, Blackstone Cleantech Venture Partners, bringing the [...]
Roche NimbleGen Launches CGH 12x135K Microarrays for Detection of CopyNumber Variation
November 19, 2008
Roche NimbleGen, Inc. has launched NimbleGen Comparative Genomic Hybridization (CGH) microarrays in a 12x135K format for analysis of DNA copy number variation. NimbleGen CGH 12x135K arrays allow simultaneous analysis of 12 independent sample pairs on a single microarray slide, each with 135,000 empirically tested long oligonucleotide probes. This new array format will enable rapid and [...]
MDS Inc. Announces Appointment of James S.A. MacDonald as Chairman of Board of Directors
November 19, 2008
John T. Mayberry Decides to Step Down as Chairman TORONTO, Nov. 19 - MDS Inc. (TSX: MDS - News; NYSE: MDZ - News), a leading provider of products and services to the global life-sciences markets, today announced the appointment of James S.A. MacDonald as Chairman of the Company's Board of Directors. Mr. MacDonald, whose appointment [...]
Free Symyx Draw 3.1 Download for Academic and Non-Commercial Personal Use
November 19, 2008
Innovative Chemical Structure Drawing Software Replaces ISIS/Draw, Offers Superior Publication-Quality Graphics SANTA CLARA, CA--Nov 19, 2008 -- Symyx Technologies, Inc. (NasdaqGS:SMMX - News) today announced that Symyx Draw 3.1, the chemical drawing application that replaces industry-leading ISIS/Draw, is now available for download at no charge for academic and non-commercial personal use (www.symyx.com/getdraw). Symyx Draw 3.1 [...]
November 19, 2008
Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced the preliminary results of elections made by Applied Biosystems stockholders regarding their preferences as to the form of merger consideration they will receive in the pending acquisition of Applied Biosystems by Invitrogen. The election deadline for Applied Biosystems stockholders to have made merger consideration elections [...]
November 19, 2008
Wednesday November 19, 7:00 am ET BILLERICA, Mass.--Bruker BioSpin announces today that it has received an order from King Abdullah University of Science and Technology (KAUST) for ten (10) Nuclear Magnetic Resonance (NMR) spectrometers valued at close to $20 million, including Bruker’s flagship 950 MHz superconducting NMR magnet. KAUST is a new graduate-level research university [...]
November 19, 2008
QIAGEN's Digene HPV Test Selected for World's First National HPV Screening Program MEXICO CITY, Mexico, November 19 -- In a campaign to significantly reduce the most common cancer affecting Mexican women, the Mexican Public Health Agency (Secretaria de Salud or SSA) has announced it is launching the first phase of a program that will offer [...]
FEBIT ANNOUNCES STRATEGIC INVESTMENT AND TECHNOLOGY DEVELOPMENT AGREEMENT WITH IN-Q-TEL
November 19, 2008
febit group, specialists in the field of advanced and flexible genomic analysis, today announced a strategic investment and technology development agreement with In-Q-Tel, the independent strategic investment firm that identifies innovative technology solutions to support the mission of the broader U.S. Intelligence Community. This strategic collaboration will further the development of febit’s Geniom® Technology to [...]

